Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1206594-12-8

Post Buying Request

1206594-12-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1206594-12-8 Usage

Description

4-(1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)morpholine is a complex organic compound that features a morpholine ring attached to a phenyl ring with a boron-containing group. The presence of boron in the molecule endows it with unique properties, making it valuable for applications in organic synthesis, pharmaceutical research, materials science, and industrial chemistry.

Uses

Used in Organic Synthesis:
4-(1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)morpholine is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure allows for versatile reactions and the formation of new chemical entities.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-(1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)morpholine is used as a building block for the development of new drugs. Its boron-containing group can be utilized in medicinal chemistry to create novel therapeutic agents.
Used in Materials Science:
4-(1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)morpholine is used as a component in the development of new materials with specific properties. Its unique structure and boron content can contribute to the creation of materials with tailored characteristics for various applications.
Used in Industrial Chemistry:
In industrial chemistry, 4-(1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)morpholine is used as a reagent or catalyst in various chemical processes. Its presence can enhance the efficiency and selectivity of reactions, leading to improved industrial processes.
It is important to handle and store this chemical with care due to the presence of boron, which can be hazardous if not properly managed.

Check Digit Verification of cas no

The CAS Registry Mumber 1206594-12-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,6,5,9 and 4 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1206594-12:
(9*1)+(8*2)+(7*0)+(6*6)+(5*5)+(4*9)+(3*4)+(2*1)+(1*2)=138
138 % 10 = 8
So 1206594-12-8 is a valid CAS Registry Number.

1206594-12-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl]morpholine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1206594-12-8 SDS

1206594-12-8Downstream Products

1206594-12-8Relevant articles and documents

NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

-

Page/Page column 67, (2010/04/03)

Novel [1,2,4]triazolo[1,5-a]pyridine compounds are disclosed that have a Formula represented by the Formula (I). These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, diseases involving cartilage degradation, bone and/or joint degradation, for example osteoarthritis; and/or conditions involving inflammation or immune responses, such as Crohn's disease, rheumatoid arthritis, psoriasis, allergic airways disease (e.g. asthma, rhinitis), juvenile idiopathic arthritis, colitis, inflammatory bowel diseases, endotoxin-driven disease states (e.g. complications after bypass surgery or chronic endotox in states contributing to e.g. chronic cardiac failure), diseases involving impairment of cartilage turnover (e.g. diseases involving the anabolic stimulation of chondrocytes), congenital cartilage malformations, diseases associated with hypersecretion of IL6 and transplantation rejection (e.g. organ transplant rejection) and proliferative diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1206594-12-8